Nexthera Capital

Nexthera Capital as of March 31, 2016

Portfolio Holdings for Nexthera Capital

Nexthera Capital holds 32 positions in its portfolio as reported in the March 2016 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Celgene Corporation 14.0 $14M 135k 100.09
Shire Sponsored Adr 13.6 $13M 76k 171.90
Pfizer (PFE) 13.4 $13M 436k 29.64
Allergan SHS 7.6 $7.4M 28k 268.04
Bristol Myers Squibb (BMY) 6.7 $6.5M 101k 63.88
Mylan NV Shs Euro 6.5 $6.3M 136k 46.35
Sanofi Sponsored Adr (SNY) 4.9 $4.7M 117k 40.16
Horizon Pharma SHS 3.8 $3.6M 220k 16.57
Seattle Genetics 3.7 $3.6M 103k 35.09
Lannett Company 2.8 $2.7M 150k 17.93
Concert Pharmaceuticals I equity 2.6 $2.5M 183k 13.66
Exelixis Note 4.250% 8/1 (Principal) 2.1 $2.0M 2.0M 1.00
ImmunoGen 2.0 $1.9M 228k 8.52
Adamas Pharmaceuticals 1.8 $1.7M 117k 14.46
Neurocrine Biosciences (NBIX) 1.7 $1.7M 42k 39.55
UniQure NV SHS (QURE) 1.4 $1.4M 115k 11.88
Eagle Pharmaceuticals Put Option (EGRX) 1.4 $1.3M 33k 40.52
Immune Design 1.1 $1.1M 85k 13.00
Ignyta 1.1 $1.0M 150k 6.77
Neuroderm Ord Shs 1.0 $988k 70k 14.11
Advaxis Com New 0.9 $903k 100k 9.03
Five Prime Therapeutics 0.8 $813k 20k 40.65
Lion Biotechnologies 0.8 $774k 152k 5.08
Infinity Pharmaceuticals (INFIQ) 0.8 $764k 145k 5.27
Aerie Pharmaceuticals 0.8 $733k 60k 12.16
Insmed Com Par $.01 (INSM) 0.5 $507k 40k 12.68
Progenics Pharmaceuticals 0.4 $419k 96k 4.36
Cynapsus Therapeutics Com Par No Par 0.4 $401k 34k 11.89
Biopharmx 0.4 $377k 345k 1.09
Tobira Therapeutics Inc Common Stock Usd 0.0001 0.4 $368k 45k 8.18
XenoPort 0.4 $361k 80k 4.51
Minerva Neurosciences 0.2 $209k 34k 6.13